CTLA-4 regulates allergen response by modulating GATA-3 protein level per cell

Immunology

Volumn 121, Issue 1, 2007, Pages 62-70

  Nasta, Francesca ^a   Corinti, Silvia ^b   Bonura, Angela ^c   Colombo, Paolo ^c   Di Felice, Gabriella ^b   Pioli, Claudio ^a  

^a ENEA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CNR   (Italy)

Author keywords

Allergy; Cytotoxic T lymphocyte antigen 4; GATA 3; T helper type 2 cells

Indexed keywords

ALLERGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; MONOCLONAL ANTIBODY; POLLEN ANTIGEN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOMODULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PARIETARIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PLANT PROTEINS; RECOMBINANT PROTEINS; RNA, MESSENGER; TH2 CELLS;

EID: 34047203464     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02537.x     Document Type: Article

References (53)

1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
2. Coffman RL, Seymour BW, Lebman DA, et al. The role of helper T cell production in mouse B cell differentiation and isotype regulation. Immunol Rev 1988; 102:5-28.
3. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 1998; 157:210-18.
4. Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 18:2261-3.
5. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 1998; 18:2258-61.
6. Dugas B, Renauld JC, Pene J et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993; 23:1687-92.
7. Petit-Frere C, Duglas B, Braquet P, Mencia-Huerta JM. Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology 1993; 79:146-51.
8. Murphy KM, Reiner SL. The lineage decisions of T helper cells. Nat Rev Immunol 2002; 2:933-44.
9. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100:655-69.
10. Mullen AC, High FA, Hutchins AS et al. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 2001; 292:1907-10.
11. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89:587-96.
12. Lee HJ, Takemoto N, Kurata H, Kamogawa Y, Miyatake S, O'Garra A, Arai N. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J Exp Med 2000; 192:105-11.
13. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998; 9:745-55.
14. Zhu J, Min B, Hu-Li J et al. Conditional deletion of Gata3 shows its essential function in Th1-Th2 responses. Nature Immnunol 2004; 11:1157-65.
15. Skapenko A, Leipe J, Niesner U et al. GATA-3 in human T cell helper type 2 development. J Exp Med 2004; 199:423-8.
16. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001; 1:220-8.
17. Oosterwegel MA, Mandelbrot DA, Boyd SD, Lorsbach RB, Jarrett DY, Abbas A, Sharpe AH. The role of CTLA-4 in regulating Th2 differentiation. J Immunol 1999; 163:2634-9.
18. Ubaldi V, Gatta L, Pace L, Doria G, Pioli C. CTLA-4 engagement inhibits Th2 but not Th1 cell polarization. Clin Dev Immunol 2003; 10:13-17.
19. Nasta F, Ubaldi V, Pace L, Doria G, Pioli C. CTLA-4 inhibits GATA-3 but not T-bet mRNA expression during Th cell differentiation. Immunology 2006; 117:358-67.
20. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995; 270:985-8.
21. Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J Immunol 1999; 162:5784-91.
22. Hellings PW, Vandenberghe P, Kasran A, Coorevits L, Overbergh L, Mathieu C, Ceuppens L. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur J Immunol 2002; 32:585-94.
23. Howard TD, Postma DS, Koppelman GA et al. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002; 110:743-51.
24. Lee SY, Lee YH, Shin C, Shim JJ, Kang KH, Yoo SH, In KH. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002; 122:171-6.
25. Colombo P, Bonura A, Costa MA, Izzo V, Passantino R, Locorotondo G, Amoroso S, Geraci G. The allergens of Parietaria. Int Arch Allergy Immunol 2003; 130:173-9.
26. Colombo P, Kennedy D, Ramsdale T et al. Identification of an immunodominant IgE epitope of the Parietaria judaica major allergen. J Immunol 1998; 160:2780-5.
27. Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1:405-13.
28. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996; 271:1734-6.
29. Cilio CM, Daws MR, Malashicheva A, Sentaman CL, Holmberg D. Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes. J Exp Med 1998; 188:1239-46.
30. Costa MA, Colombo P, Izzo V et al. cDNA cloning, expression and primary structure of Parj1, a major allergen of Parietaria judaica pollen. FEBS Lett 1994; 341:182-6.
31. Duro G, Colombo P, Costa AM, Izzo V et al. Isolation and characterization of two cDNA clones coding for isoforms of the Parietaria judaica major allergen Parj 1.0101. Int Arch Allergy Immunol 1997; 112:348-5.
32. Orlandi A, Grasso F, Corinti S, Marinaro M, Bonura A, Boirivant M. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization. Clin Exp Allergy 2004; 34:470-7.
33. Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183:2541-50.
34. Pioli C, Gatta L, Frasca D, Doria G. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IκBα degradation and RelA activation. Eur J Immunol 1999; 29:856-63.
35. Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: a negative regulator of autoimmune disease. J Exp Med 1996; 184:783-8.
36. Perrin PJ, Maldonato JH, Davis AT, June TH, Racke MK. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol 1996; 157:1333-6.
37. Alenmyr L, Matheu V, Uller L, et al. Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance. Scand J Immunol 2005; 62:437-44.
38. Fowler S, Powrie F. CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur J Immunol 2002; 32:2997-3006.
39. Chen Y, Ma Y, Chen Y. Roles of cytotoxic T-lymphocyte-associated antigen-4 in the inductive phase of oral tolerance. Immunology 2002; 105:171-80.
40. + T cells toward the Th1 subset by CTLA-4 co stimulation. J Immunol 2000; 164:3554-62.
41. Ranger AM, Das MP, Kuchroo VK, Glimcher LH. B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int Immunol 1996; 8:1549-60.
42. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
43. Brown JA, Titus RG, Natavi N, Glimcher LH. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J Infect Dis 1996; 174:1303-8.
44. Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004; 21:401-13.
45. Pioli C, Gatta L, Ubaldi V, Doria G. Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor. J Immunol 2000; 165:5530-6.
46. Agarwal S, Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 1998; 9:765-75.
47. Martins GA, Hutchins AS, Reiner SL. Transcriptional activators of helper T cell fate are required for establishment but not maintenance of signature cytokine expression. J Immunol 2005; 175:5981-5.
48. Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. CTLA-4 regulates the requirement for cytokine-induced signals in Th2 lineage commitment. Nat Immunol 2003; 4:182-8.
49. + cells. J Exp Med 2001; 194:1461-71.
50. Miaw SC, Choi A, Yu E, Kishikawa H, Ho IC. ROG, repressor of GATA, regulate the expression of cytokine gene. Immunity 2000; 12:323-33.
51. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997; 272:21597-603.
52. Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol 2003; 4:616-23.
53. Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 2005; 307:430-3.